Amalia Bosia

Recent Advances in Medicinal Chemistry

Fabio Polticelli, Ann Nowé, Hendrik Fuchs, 2017 .

Activation of Nuclear Factor-κB Pathway by Simvastatin and RhoA Silencing Increases Doxorubicin Cytotoxicity in Human Colon Cancer HT29 Cells

Amalia Bosia, Dario Ghigo, Elisabetta Aldieri, 2008, Molecular Pharmacology.

RhoA Silencing Reverts the Resistance to Doxorubicin in Human Colon Cancer Cells

Amalia Bosia, Dario Ghigo, Elisabetta Aldieri, 2008, Molecular Cancer Research.